Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -59.31%5.6M | -26.33%43.81M | -29.62%7.22M | -47.42%13.39M | 7.51%10.76M | 48.01%59.47M | -13.73%10.25M | 46.99%13.76M | 175.22%25.46M | 3.27%10M |
| Cost of revenue | -51.57%4.1M | -3.81%37.64M | -50.59%5.95M | 8.20%10.62M | 36.61%8.69M | 66.80%39.13M | 68.82%12.05M | 38.66%8.46M | 85.10%9.82M | 29.31%6.36M |
| Gross profit | -71.68%1.5M | -69.64%6.18M | 170.50%1.26M | -82.32%2.77M | -43.32%2.07M | 21.65%20.34M | -137.75%-1.79M | 62.60%5.3M | 296.30%15.64M | -23.59%3.64M |
| Operating expense | -0.13%4.74M | -35.85%18.72M | -42.83%4.98M | 8.51%5.84M | 10.31%4.75M | -25.34%29.18M | -35.19%8.7M | 64.04%4.74M | -70.84%5.38M | -0.60%4.31M |
| Staff costs | 6.80%2.18M | 2.83%9.31M | -14.74%2.24M | 6.51%2.29M | 14.30%2.27M | 9.94%9.06M | --2.63M | --2.05M | --2.15M | --1.99M |
| Depreciation and amortization | 19.25%799K | 32.05%2.99M | -34.09%779K | 7.51%730K | 39.54%727K | -17.77%2.27M | --1.18M | --670K | --679K | --521K |
| -Depreciation | 19.25%799K | 32.05%2.99M | -34.09%779K | 7.51%730K | 39.54%727K | -17.77%2.27M | --1.18M | --670K | --679K | --521K |
| Other operating expenses | -13.50%1.76M | -64.08%6.42M | -60.01%1.96M | 10.46%2.82M | -2.55%1.76M | -36.43%17.86M | 563.42%4.89M | -44.46%2.03M | -86.65%2.55M | -60.91%1.8M |
| Total other operating income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -98.69%10K | ---- | ---- |
| Operating profit | -686.59%-3.24M | -41.91%-12.54M | 64.64%-3.71M | -129.95%-3.07M | -304.06%-2.69M | 60.48%-8.84M | -20.94%-10.5M | 51.23%552K | 170.76%10.26M | -253.23%-665K |
| Net non-operating interest income (expenses) | -130.58%-1.03M | -111.60%-2.66M | -73.50%-694K | -130.18%-778K | -85.06%-446K | -26.40%-1.26M | -173.85%-400K | -92.27%-448K | 3.43%-338K | 2.82%-241K |
| Non-operating interest income | ---- | ---- | ---- | ---- | ---- | --1.04K | ---- | ---- | ---- | ---- |
| Non-operating interest expense | 130.58%1.03M | 111.60%2.66M | 73.50%694K | 130.18%778K | 85.06%446K | 27.29%1.26M | 187.67%400K | 92.27%448K | -3.43%338K | -2.82%241K |
| Total other finance cost | ---- | ---- | ---- | ---- | ---- | 8,863.32%629.23K | ---- | ---- | ---- | ---- |
| Net investment income | 70.86K | |||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 0 | 0 | 0 | -2,346.49%-8.33M | -8.33M | 0 | -8.33M | |||
| Less:Other special charges | ---- | ---- | ---- | ---- | ---- | 274,038.80%8.33M | --8.33M | ---- | --8.33M | ---- |
| Less:Write off | ---- | ---- | ---- | ---- | ---- | 197.78%1.02M | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | -1,970.00%-187K | -12.15%571K | -88.99%38K | 198.21%334K | 7.65%197K | 328.87%650K | 345K | 10K | 112K | 183K |
| Income before tax | -4,010.53%-4.46M | 9.68%-16.05M | 76.86%-4.37M | -305.55%-3.52M | -306.09%-2.94M | 24.53%-17.77M | -109.43%-18.88M | -13.64%114K | 111.52%1.71M | -488.71%-723K |
| Income tax | 0 | 0 | 0 | 0 | 0 | 1,696,219.02%2.77M | 8,784.86%2.77M | 0 | 0 | 0 |
| Net income | -4,010.53%-4.46M | 21.84%-16.05M | 79.82%-4.37M | -305.55%-3.52M | -306.09%-2.94M | 12.79%-20.54M | -140.96%-21.64M | 14.00%114K | 111.52%1.71M | -488.71%-723K |
| Net income continuous operations | -4,010.53%-4.46M | 21.84%-16.05M | 79.82%-4.37M | -305.55%-3.52M | -306.09%-2.94M | 12.79%-20.54M | -140.96%-21.64M | 14.00%114K | 111.52%1.71M | -488.71%-723K |
| Noncontrolling interests | -3.66%-595K | 23.73%-2.45M | 99.94%-1K | 1.80%-601K | -56.83%-654K | 75.72%-3.22M | 75.02%-1.61M | 86.24%-574K | 78.62%-612K | -621.25%-417K |
| Net income attributable to the company | -661.63%-3.86M | 21.49%-13.6M | 78.20%-4.37M | -225.53%-2.92M | -645.75%-2.28M | -68.07%-17.32M | -692.24%-20.03M | -83.90%688K | 119.37%2.32M | -388.68%-306K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | -600K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -661.63%-3.86M | 21.49%-13.6M | 81.19%-3.77M | -225.53%-2.92M | -645.75%-2.28M | -68.07%-17.32M | -692.24%-20.03M | -83.90%688K | 119.37%2.32M | -388.68%-306K |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -591.67%-0.0059 | 21.43%-0.0209 | 81.17%-0.0058 | -215.38%-0.0045 | -600.00%-0.0035 | -52.87%-0.0266 | -633.33%-0.0308 | -83.33%0.0012 | 100.19%0.0039 | -350.00%-0.0005 |
| Diluted earnings per share | -591.67%-0.0059 | 21.43%-0.0209 | 81.17%-0.0058 | -215.38%-0.0045 | -600.00%-0.0035 | -52.87%-0.0266 | -620.47%-0.0308 | -83.33%0.0012 | 100.19%0.0039 | -350.00%-0.0005 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.